Internal Medicine

World-leading virologist and AIDS researcher David Ho, MD, joins the inaugural podcast episode.

The fast-acting therapy has been long-discussed for its unique benefits to severe patients—as well as notable concerns surrounding its administration.

The most common adverse events were injection-site reactions and headaches.

The pandemic has burdened blood drives nationally. A new sickle cell drug keeps patients from needing as many transfusions.

Pediatrics is leading the way in prescribing nature.

In a study presented at ASRS 2020, investigators find an improvement in DRSS is not correlated with a change in best corrected visual acuity.

A large proportion of nAMD patients treated with anti-VEGF therapies continue to have active disease and fluid.

A look at how the specialty functions in telemedicine, and how it could work better with primary care physicians and endocrinologists.

A look at how primary care patients begin to present with diabetic retinopathy risk.

More than 40% of critically ill patients died within 90 days regardless of timing of renal-replacement therapy.

New research is comparing the long-term risk of death from solid cancers in patients treated with radioactive iodine, antithyroid drugs, or surgery for hyperthyroidism.

Although nature is beneficial, other social determinants of health might need to be addressed more imminently.

Canagliflozin is a known treatment for kidney disease, as well as heart failure in patients with type 2 diabetes and diabetic nephropathy.

The approval represents the second approved treatment of the conditions associated with narcolepsy patients at least 7 years old.

An expert explains why little progress has been made in disease prevalence and burden in the US.

An expert discusses nature counseling, how to prescribe it, and who might benefit from it.

The association of DAA treatment with mortality did not differ by sex in the cirrhosis group.

Women who have recurrent infections have fewer types of bacteria in their urine than those who do not have infections.

A new study suggests supplemental cinnamon could help prevent prediabetes from converting to type 2 diabetes.

The vaccine induced T cell response in about 2 weeks, and antibody response in about 4 weeks, among 1000-plus healthy adults.

Cataracts and diabetic retinopathy are the 2 leading causes of acquired blindness worldwide.

A secondary ACCELERATE assessment shows a particular set of patients who may benefit from Lp(a)-lowering novel agents.

There is a growing amount of literature showing the physical, mental, and social benefits of nature.

New scoring model is based on an eight-point threshold to accurately predict patients at a low risk of adverse outcomes.

AI can help make up for missed appointments and screening.